You just read:

Haemonetics Reports 1st Quarter Fiscal 2016 Revenue of $213 Million and Adjusted EPS of $0.35, Reaffirms Full Fiscal Year Guidance

News provided by

Haemonetics Corporation

Jul 27, 2015, 06:00 ET